ISRCTN49693355已完成未知
A randomised prospective double-blind, placebo controlled trial of prophylactic oral levofloxacin following chemotherapy for lymphoma and solid tumours
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 1,500 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16148284 results
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult who has given informed consent
- •2. Solid tumour or lymphoma
- •3. First cycle of anti-neoplastic chemotherapy
- •4. Anticipated neutrophil nadir <0.5 x 10^9/l
- •5. Normal serum creatinine or creatinine clearance >40 ml/min
- •6. Adequate contraceptive measures in place
排除标准
- •1. Human Immunodeficiency Virus (HIV) positive
- •2. Pregnant or breast feeding
- •3. Epileptic
- •4. Planned granulocyte colony-stimulating factor (GCSF) or stem cell support
- •5. Currently taking antibacterial therapy or prophylaxis
- •6. History of adverse effects caused by fluoroquinolone agent
- •7. Previous participation in the Significant trial
研究者
相似试验
已完成
不适用
A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiencyISRCTN46268487Cardiff University (UK)40
已完成
不适用
Double-blind, placebo-controlled randomised trial of alpha-tocopherol and oxpentifylline in patients with radiation fibrosisCancerBreast cancerISRCTN45257322Cancer Research UK (CRUK) (UK)
已完成
2 期
A randomised, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexateRheumatoid arthritisISRCTN49455679Academic Medical Center (AMC) (The Netherlands)191
已完成
不适用
A double blind, randomised, placebo controlled parallel group study of cannabis based medicine extract (CBME), in the treatment of peripheral neuropathic pain characterised by allodyniaPeripheral neuropathic pain, characterised by allodyniaSigns and SymptomsPain, not elsewhere classifiedISRCTN38250575GW Pharma Ltd (UK)145
已完成
2 期
A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced Non-Small Cell Lung Cancer (NSCLC)on-small cell lung cancerMalignant neoplasm of lungCancerISRCTN77341241Sponsor not defined - Record supplied by London Lung Cancer Group722